Results of MEDICA in November 2021

Results of attending MEDICA, an international medical device exhibition in Düsseldorf, Germany from November 15 to 18, 2021

1. Because of COVID19, MEDICA2021, the number of participating companies and buyers is 1/2 to 2/3 compared to the previous year, and most of them are European buyers.

- Europe: The ACPI system is suitable for advanced markets, as it is necessary to work hard due to hundreds of anticancer drug preparations per 10 minutes and 5 to 6 hours (less cases per case (less than 1 minute per case) for 5 to 6 hours.

2. Introduction and demonstration of products visited to the headquarter of German buyers and discussed ACPI and pump sales rights.

- Sales person cannot visit hospitals due to COVID-19, and it will be conducted after market research with brooch data based on demonstrations and product introduction.

- Anti-cancer drug preparation is a system in which specialized companies administer it to patients delivered to related hospitals after preparation, and is interested in the mass preparation Anyfusion  Multi ACPi Pro system.

3. Spanish Buyer

- Spanish market EZ Regular is negotiating the final price of 600,000 units (about 800 million won) for three years by requesting prices for about 800,000 units of five types over the past three years, and I011 types I011 (about 800 million won)

- Negotiating price requests for 1 million units (about 2 billion won) in the first two years of EZ Regular in the U.S. market.

- Introduction and demonstration of Anyfusion ACPI system products, receipt of a large number of Spanish brooches, introduction to oncology authority, and discussion of sales in Spain according to the results.

4. Italian Buyer

1) The first buyer: Anyfusion ACPI system, same concept product technology development plan -> Anyfusion ACPI system, company-developed Infusion and syringe pump, consultation on integration of anticancer drug injection program and ACPI system vendor recommendation system.

2) Second buyer: negotiating pump purchase offer with ACPI system on November 23rd.

5. Others: First introduction of COVID-19 to overseas presidents in 2019 confirmed a meaningful response (same as the Japanese market survey)

- Introduction of Anyfusio ACPI systems in Switzerland, Poland and the UK, high interest, and negotiations are expected after market research.

Both domestic and foreign countries are not smooth in entering and leaving the country due to COVID-19, so it will be difficult to develop and display overseas markets until COVID-19 stabilizes.

In 2022, Dubai Arab Health is unlikely to participate, and at the request of Saudi Arabia Buyer in April, the request for the Anyfusion pump and ACPI system medical staff invitation launching event should be conducted at the two city hotels according to the COVID-19 situation.

In Japan, the results of a market survey on ACPI systems showed that all hospitals were very interested, so we planned to explain and demonstrate the hospital and PMDA certification in early December with the final mass-produced products, but the entry process is too strict.

Thank you.